Search…

TenoMab Biopharma submits IPO registration on the ChiNext board, an innovative biopharmaceutical company dedicated to alternative therapy for blood products.

25/05/2026

According to the Securities Times app, on May 22, Zhuhai Tainuo Meibo Pharmaceutical Co., Ltd. (referred to as Tainuo Meibo) applied for a change in the IPO review status of the Shanghai Stock Exchange's Sci-Tech Innovation Board to "submitted for registration". Huatai United Securities is the sponsor institution, and it plans to raise 1.5 billion yuan.

Latest

3 m ago

Zhongjin: Valuations of US stocks in the medical equipment sector have bottomed out.

5 m ago

Wuhan Municipal Party Secretary Sheng Yuechun Holds Talks with Entrepreneurs in the Integrated Circuit Industry.

5 m ago

According to the price-earnings ratio adjusted for economic cycles, the S&P 500 index is currently valued at 40.8 times. This indicator was popularized by Yale University economist Robert Shiller, who won the Nobel Prize in Economics in 2013 for his research on asset prices. In Shiller's 145 years of data records, this indicator only surpassed the 40 mark once, around the early 2000s before and after the peak of the Internet bubble.

6 m ago

The U.S. stock market welcomes a historic high moment while consumer confidence has never been so low.

9 m ago

The People's Bank of China has 304.5 billion yuan worth of reverse repurchase agreements maturing in the open market this week.

See all latest